- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01891032
Assessment of Acute Renal Injury During Partial Nephrectomy Using Neutrophil Gelatinase-associated Lipocalin (NGAL): Prospective Comparative Study Between Open, Video-assisted Minilaparotomy, Laparoscopic, and Robotic-assisted Laparoscopic Surgery
July 24, 2014 updated by: Yonsei University
Urinary Neutrophil gelatinase associated lipocalin (NGAL) has been recently reported to be related with the degree of acute kidney injury.
We are trying to analyze whether it is related with the grade of acute kiney injury after partial nephrectomy and there is any difference between the kinds of surgery.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
160
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
- the adult patients with open partial nephrectomy
- the adult patients with laparoscopic partial nephrectomy
- the adult patients with VAMS partial nephrectomy, 4: the adult patients with robotic partial nephrectomy
Description
Inclusion Criteria:
- adults patient more than 20 years old with ASA score 1-3
- the patients who undergoing partial nephrectomy for the renal mass less than 7 cm
Exclusion Criteria:
- the patient with previous history with renal surgery
- the patient with bilateral partial nephrectomy
- the patient with synchronous operation for other intraperitoneal surgery
- the renal mass more than 7 cm
- previous kinds of surgery is changed into other kinds due to bleeding, etc
- the patient with serum Cr level more than 1.4 mg/dl
- the patient who does not understand the consent form
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
the patients with open partial nephrectomy
the adult patients with open partial nephrectomy
|
|
laparoscopic
the adult patients with laparoscopic partial nephrectomy
|
|
VAMS
the adult patients with VAMS partial nephrectomy
|
|
robotic
the adult patients with robotic partial nephrectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The level of urinary NGAL
Time Frame: changes from Preoperative, postop 3hr, 24hr, 48hrs after partial nephrectomy
|
Analysis of correlation between the level of preoperative and postoperative urinary NGAL
|
changes from Preoperative, postop 3hr, 24hr, 48hrs after partial nephrectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
June 27, 2013
First Submitted That Met QC Criteria
June 27, 2013
First Posted (Estimate)
July 2, 2013
Study Record Updates
Last Update Posted (Estimate)
July 28, 2014
Last Update Submitted That Met QC Criteria
July 24, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 4-2013-0261
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on the Patients With Partial Nephrectomy
-
Integra LifeSciences CorporationCompletedBenign, Malignant Tumors or Other Soft Tissue Removal | Nephrectomy or Partial Nephrectomy With Parenchyma RemovalGermany, Italy
-
270SurgicalNot yet recruitingLaparoscopy | Nephrectomy | Partial NephrectomyIsrael
-
Distalmotion SACompletedHysterectomy | Partial Nephrectomy | Right ColectomySwitzerland, Germany, France
-
First Affiliated Hospital of Fujian Medical UniversityThe Second Affiliated Hospital of Fujian Medical University; The First Affiliated...Active, not recruitingPartial Nephrectomy | Renal Hilum Tumors | Urinary LeakageChina
-
The Cleveland ClinicTerminated
-
Milton S. Hershey Medical CenterTerminatedNephrectomy | Partial Nephrectomy | Incision Site DiscomfortUnited States
-
Yonsei UniversityCompletedPatients Undergoing Laparoscopic NephrectomyKorea, Republic of
-
University of BaselEnrolling by invitationClasp-retained Partial Dentures | Extracoronal Adhesive Attachment | Patients Satisfaction With Removable Dental ProsthesesSwitzerland
-
AstraZenecaCompletedAll Patients Treated With the ProductJapan
-
University Hospital of North NorwayActive, not recruitingSurvival of the Implants With Revision as Endpoint | Clinical Performance With HHS | Patients Satisfaction With the Hip ImplantNorway